Axillary Lymph Node Dissection
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Omission of ALND in Breast Cancer Patients With Axillary pCR
Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy
Evaluating Hemopatch in Reducing Seroma Related Complications Following Axillary Lymph Node Dissection: a Pilot Study
Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery
Nomogram to Predict Breast Cancer Related Lymphedema
Upper Extremity Lymphatic Mapping for Breast Cancer Patients
Manual Therapy in Postoperative Breast Cancer